Zobrazeno 1 - 10
of 429
pro vyhledávání: '"S. Geisse"'
Autor:
S Geisse, Anne T. Bruinvels, Bernd Sommer, Mark D. Tricklebank, Daniel Hoyer, Lucien Gazi, E. Schüpbach, Philippe Schoeffter, M Danzeisen, I. Bobirnac
Publikováno v:
British Journal of Pharmacology. 124:889-896
1. Dopamine D4 receptor antagonists are being developed by several pharmaceutical companies as putative novel antipsychotics, possibly with low propensity to side-effects. Two such compounds, L-745,870 and U-101958 have been recently introduced. 2. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9beb34fff9900f03be289828f507c57d
https://doi.org/10.1038/sj.bjp.0701921
https://doi.org/10.1038/sj.bjp.0701921
Autor:
Rigato, Annafrancesca1,2 (AUTHOR), Meng, Huicheng1 (AUTHOR), Chardes, Claire2 (AUTHOR), Runions, Adam3 (AUTHOR), Abouakil, Faris1 (AUTHOR), Smith, Richard S.4 (AUTHOR), LeGoff, Loïc1 (AUTHOR) loic.le-goff@univ-amu.fr
Publikováno v:
PLoS Biology. 6/13/2024, Vol. 22 Issue 6, p1-30. 30p.
Publikováno v:
Journal of Biological Chemistry. 266:19469-19474
It is recognized that insulin-like growth factors (IGFs) are bound to specific high-affinity insulin-like growth factor-binding proteins (IGFBPs). The role of IGFBPs in bone metabolism is not well established. The effect of recombinant human [Cys281]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ed5d8a8c4f35ffe4a850077c1dded08
https://doi.org/10.1016/s0021-9258(18)55019-5
https://doi.org/10.1016/s0021-9258(18)55019-5
Publikováno v:
Animal Cell Technology Meets Genomics ISBN: 9781402027918
Expression of recombinant proteins using mammalian expression systems is still considered to be costly, tedious and labour-intensive, and thus disadvantageous to high throughput applications. However, a breakthrough in the rapid generation of recombi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b94a4538cc9fb29df85ea50b75ae434
https://doi.org/10.1007/1-4020-3103-3_73
https://doi.org/10.1007/1-4020-3103-3_73
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 293(2)
Nateglinide (A-4166) is an amino acid derivative with insulinotrophic action in clinical development for treatment of type 2 diabetes. The aim of this study was to determine whether nateglinide's interaction at the K(ATP) channel/sulfonylurea recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81099ad377f943b75fa6cc2189fac99d
https://pubmed.ncbi.nlm.nih.gov/10773014
https://pubmed.ncbi.nlm.nih.gov/10773014
Autor:
S, Geisse, H P, Kocher
Publikováno v:
Methods in enzymology. 306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::194f17994e4a186cf77594b57a8c8256
https://pubmed.ncbi.nlm.nih.gov/10432446
https://pubmed.ncbi.nlm.nih.gov/10432446
Publikováno v:
The Journal of biological chemistry. 266(29)
It is recognized that insulin-like growth factors (IGFs) are bound to specific high-affinity insulin-like growth factor-binding proteins (IGFBPs). The role of IGFBPs in bone metabolism is not well established. The effect of recombinant human [Cys281]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fb873f0ec406251cc032f421ad0023f
https://pubmed.ncbi.nlm.nih.gov/1717466
https://pubmed.ncbi.nlm.nih.gov/1717466
Publikováno v:
Lymphokine and cytokine research. 10(4)
The human interleukin-3 gene was cloned in 1986 and the biochemical and biological properties of recombinant human interleukin-3 (rhuIL-3) protein were described. In this report we compare rhuIL-3 with nonrecombinant, natural huIL-3, purified from th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::12a06c7b22ca573374bfe0573fd04590
https://pubmed.ncbi.nlm.nih.gov/1932378
https://pubmed.ncbi.nlm.nih.gov/1932378
Publikováno v:
The New biologist. 3(3)
The structurally unrelated immunosuppressive drugs cyclosporin A (Sandimmun) and FK-506 both interfere with the process of T-cell proliferation by blocking the transcription of the T-cell growth factor interleukin-2 (IL-2). Here we demonstrate that t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f51898c704a73b74416c4146d5f6f37d
https://pubmed.ncbi.nlm.nih.gov/1715185
https://pubmed.ncbi.nlm.nih.gov/1715185
Autor:
Janakiraman, Mathangi1 (AUTHOR), Leliavski, Alexei1 (AUTHOR), Varadarajulu, Jeeva1 (AUTHOR), Jenne, Dieter2 (AUTHOR), Krishnamoorthy, Gurumoorthy1 (AUTHOR) gurumoorthy.krishnamoorthy@gmail.com
Publikováno v:
Journal of Neuroinflammation. 12/6/2023, Vol. 20 Issue 1, p1-13. 13p.